Hana Pharm Co., Ltd. (KRX: 293480)
South Korea
· Delayed Price · Currency is KRW
10,920
+70 (0.65%)
Dec 20, 2024, 3:30 PM KST
Hana Pharm Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2017 | FY 2016 |
---|---|---|---|
Period Ending | Dec '17 Dec 31, 2017 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
Cash & Equivalents | 12,940 | 12,940 | 1,389 |
Short-Term Investments | 3,550 | 3,550 | 1,770 |
Cash & Short-Term Investments | 16,490 | 16,490 | 3,159 |
Cash Growth | - | 422.04% | - |
Accounts Receivable | 37,525 | 37,525 | 34,399 |
Other Receivables | 5,535 | 5,535 | 4,234 |
Receivables | 43,060 | 43,060 | 38,633 |
Inventory | 19,270 | 19,270 | 18,027 |
Prepaid Expenses | 32.46 | 32.46 | 34.39 |
Other Current Assets | 545.72 | 545.72 | 623.38 |
Total Current Assets | 79,398 | 79,398 | 60,476 |
Property, Plant & Equipment | 46,653 | 46,653 | 49,664 |
Long-Term Investments | 1,233 | 1,233 | 1,152 |
Other Intangible Assets | 3,384 | 3,384 | 1,978 |
Long-Term Deferred Charges | - | - | 8.41 |
Other Long-Term Assets | 10,883 | 10,883 | 1,315 |
Total Assets | 141,551 | 141,551 | 114,592 |
Accounts Payable | 7,352 | 7,352 | 6,921 |
Accrued Expenses | 61.39 | 61.39 | 100.85 |
Short-Term Debt | 1,730 | 1,730 | 1,751 |
Current Portion of Long-Term Debt | 21,102 | 21,102 | 8,028 |
Current Income Taxes Payable | 4,737 | 4,737 | 3,552 |
Other Current Liabilities | 13,731 | 13,731 | 13,742 |
Total Current Liabilities | 48,713 | 48,713 | 34,095 |
Long-Term Debt | 6,214 | 6,214 | 21,155 |
Long-Term Deferred Tax Liabilities | 1,213 | 1,213 | 1,464 |
Other Long-Term Liabilities | 1,435 | 1,435 | 127.76 |
Total Liabilities | 60,253 | 60,253 | 59,108 |
Common Stock | 6,059 | 6,059 | 4,872 |
Additional Paid-In Capital | 3,200 | 3,200 | 2,495 |
Retained Earnings | 69,506 | 69,506 | 45,958 |
Comprehensive Income & Other | 2,174 | 2,174 | 2,160 |
Total Common Equity | 80,940 | 80,940 | 55,485 |
Minority Interest | 357.85 | 357.85 | - |
Shareholders' Equity | 81,298 | 81,298 | 55,485 |
Total Liabilities & Equity | 141,551 | 141,551 | 114,592 |
Total Debt | 29,045 | 29,045 | 30,934 |
Net Cash (Debt) | -12,555 | -12,555 | -27,775 |
Net Cash Per Share | -1158.68 | -1158.68 | -3582.02 |
Filing Date Shares Outstanding | 10.84 | 10.84 | 7.75 |
Total Common Shares Outstanding | 10.84 | 10.84 | 7.75 |
Working Capital | 30,685 | 30,685 | 26,381 |
Book Value Per Share | 7469.67 | 7469.67 | 7155.67 |
Tangible Book Value | 77,556 | 77,556 | 53,507 |
Tangible Book Value Per Share | 7157.40 | 7157.40 | 6900.60 |
Land | 15,937 | 15,937 | 15,937 |
Buildings | 31,746 | 31,746 | 31,696 |
Machinery | 27,690 | 27,690 | 26,894 |
Construction In Progress | 559.41 | 559.41 | 2,231 |
Source: S&P Capital IQ. Standard template. Financial Sources.